Moleculin Biotech Inc Sustainability Reports
Moleculin Biotech, Inc. operates as a late-stage pharmaceutical development company. It focuses on developing therapeutic drug candidates for the treatment of highly resistant tumors and viruses.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300IB1TLJZCHEO353
2 reports from 2017 to 2018
Company Profile
Moleculin Biotech, Inc. operates as a late-stage pharmaceutical development company. It focuses on developing therapeutic drug candidates for the treatment of highly resistant tumors and viruses.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
